Preclinical studies have previously explored the effects of anti-OPG antibodies in murine models, highlighting the role that anti-OPG antibodies can play in developing pulmonary arterial hypertension (PAH) through promoting cell survival, pro-proliferative, and pro-migratory signaling. This evidence concerns the gene TNFRSF11B and pulmonary arterial hypertension.